Set in the not-so-distant future, the production tells the story of an epidemic of organ failures that devastates the planet, killing tens of millions. As scientists feverishly make plans for a massive organ harvest program, a multi-billion dollar biotech company called GeneCo begins to manufacture salvation -- for a price -- offering simple payment plans to those lacking the necessary funds to purchase new body parts outright. But all financed organs are subject to default procedures, including repossession at the hand of the notorious organ repo men.